Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| PACK | 8-K | neutral | 4/10 | Ranpak reported Q3 2026 net revenue of $101.9M, up 2.3% YoY (3.4% constant currency), and a net loss of $7.2M, improved | Oct 29, 2026 |
| SILC | PRESS-RELEASE | bullish | 6/10 | The company raised full-year 2026 revenue guidance to $96-98M (57% YoY growth), citing strong Design Win momentum and an | Oct 29, 2026 |
| DAIC | PRESS-RELEASE | neutral | 4/10 | CID Holdco (Dot Ai) announced that the Nasdaq Hearings Panel granted its request for continued listing, subject to trans | Oct 29, 2026 |
| BWA | 8-K | neutral | 5/10 | BorgWarner reported Q3 2026 adjusted EPS of $1.39, beating consensus of $1.25 by 11.2%, while net sales of $3.487B decli | Oct 29, 2026 |
| CARE | 8-K | neutral | 2/10 | Carter Bankshares, Inc. announced a quarterly cash dividend of $0.10 per share, payable on November 23, 2026 to sharehol | Oct 29, 2026 |
| ZTG | 6-K | bearish | 6/10 | Zenta Group files a 6-K updating shareholders on its post-acquisition status of ZentoAI, including that ZentoAI has no c | Oct 29, 2026 |
| CARE | 8-K | bearish | 5/10 | Carter Bankshares reported Q3 2026 GAAP diluted EPS of $0.35, below the consensus estimate of $0.53, a miss of 34.0%. Ne | Oct 29, 2026 |
| CHRS | 8-K | bullish | 6/10 | Coherus Oncology announced interim clinical data from the TREGCHECK program for tagmokitug, an investigational CCR8 anti | Oct 29, 2026 |
| BUD | 6-K | neutral | 5/10 | AB InBev reported nine-month 2026 results with revenue of USD 48,439M (+10.7% YoY) and Normalized EBITDA of USD 17,332M | Oct 29, 2026 |
| WRD | 6-K | neutral | 4/10 | WeRide Inc. announced that its wholly-owned subsidiary Jingshuo entered into a capital increase agreement with external | Oct 29, 2026 |
| HTO | 424B5 | bearish | 5/10 | H2O America is offering 6,500,000 Equity Units (Corporate Units) at $50 per unit, each consisting of a purchase contract | Oct 29, 2026 |
| BUD | 6-K | bullish | 6/10 | AB InBev reported Q3 2026 results with organic revenue growth of 4.9% and Underlying EPS of $1.21, up 22.4% year-over-ye | Oct 29, 2026 |
| PWP | 8-K | bullish | 6/10 | Perella Weinberg Partners reported Q3 2026 revenue of $251.4M, up 53% YoY, and adjusted EPS of $0.39, well above the $0. | Oct 29, 2026 |
| NSP | 8-K | bullish | 6/10 | Insperity reported Q3 2026 results with a net loss improving 95% to $1 million and adjusted EBITDA surging 210% to $31 m | Oct 29, 2026 |
| AROW | 8-K | neutral | 5/10 | Arrow Financial reported Q3 2026 GAAP net income of $5.7M ($0.31 EPS), down from $11.0M ($0.66 EPS) in Q2 2026, due to $ | Oct 29, 2026 |
| XRX | 8-K | bearish | 6/10 | Xerox entered into an Exchange Support Agreement with holders of approximately 31.1% of its $556 million 5.500% Senior N | Oct 29, 2026 |
| MA | 8-K | bullish | 6/10 | Mastercard reported Q3 2026 net revenue of $9.8B (+14% YoY) and GAAP diluted EPS of $5.28, both above consensus estimate | Oct 29, 2026 |
| HTO | PRESS-RELEASE | bearish | 6/10 | H2O America commenced an underwritten public offering of 6.5 million equity units with a $325 million aggregate stated a | Oct 29, 2026 |
| SPAI | PRESS-RELEASE | neutral | 3/10 | Safe Pro Group completed all milestones under a Phase I SBIR contract from AFWERX, developing an AI dataset for Foreign | Oct 29, 2026 |
| FSS | PRESS-RELEASE | neutral | 4/10 | The in-line results and modest revenue miss suggest limited near-term stock-moving catalyst from this release. | Oct 29, 2026 |
| PATK | PRESS-RELEASE | neutral | 5/10 | Patrick Industries reported Q3 2026 adjusted EPS of $1.03, beating the $0.99 consensus, while revenue of $975M was above | Oct 29, 2026 |
| FSTR | 8-K | neutral | 5/10 | L.B. Foster Company, through its subsidiary CXT Incorporated, completed the acquisition of the operating assets of Dulwo | Oct 29, 2026 |
| HAFC | 8-K | neutral | 2/10 | Hanmi Financial Corp declared a Q4 2026 cash dividend of $0.28 per share, payable November 25, 2026 to holders of record | Oct 29, 2026 |
| JAGX | DEFA14A | bearish | 6/10 | Jaguar Health filed supplemental proxy materials ahead of its November 6, 2026 special meeting, disclosing that the boar | Oct 29, 2026 |
| SATL | PRESS-RELEASE | bullish | 5/10 | Satellogic announced a three-year agreement with HEO to provide non-Earth imaging services, including a seven-figure min | Oct 29, 2026 |
| MIRA | PRESS-RELEASE | neutral | 4/10 | MIRA Pharmaceuticals announced positive proof-of-concept results from a pilot mouse study of its oral obesity candidate | Oct 29, 2026 |
| PCSA | PRESS-RELEASE | bullish | 7/10 | Processa Pharmaceuticals announced FDA clearance of an IND for a Phase 2 study of VT-7208 in chronic spontaneous urticar | Oct 29, 2026 |
| ITGR | PRESS-RELEASE | bearish | 5/10 | Integer Holdings reported Q3 2026 sales of $450M (down 3.9% YoY) and adjusted EPS of $1.34, missing the consensus estima | Oct 29, 2026 |
| CETX | PRESS-RELEASE | neutral | 4/10 | Cemtrex reported Q4 FY2026 revenue of $22.7M (+22% YoY) and swung to operating income of $1.4M from a $1.2M loss a year | Oct 29, 2026 |
| COLL | PRESS-RELEASE | neutral | 2/10 | Collegium Pharmaceutical announced an expanded multi-year partnership with Boston Legacy FC, a professional women's socc | Oct 29, 2026 |